中国实用外科杂志 ›› 2024, Vol. 44 ›› Issue (11): 1243-1245.DOI: 10.19538/j.cjps.issn1005-2208.2024.11.11

• 指南(共识)解读 • 上一篇    下一篇

《乳腺肿瘤整形与乳房重建专家共识(2022年版)》腔镜手术部分解读

唐    鹏,何佳玲
  

  1. 陆军军医大学西南医院乳腺甲状腺外科,重庆 400038
  • 出版日期:2024-11-01 发布日期:2024-11-26

  • Online:2024-11-01 Published:2024-11-26

摘要: 近年来,以腔镜保留乳头乳晕皮下腺体切除术(NSM)联合假体乳房重建为代表的乳腺腔镜手术在国内广泛开展,但尚缺乏统一的技术规范。《乳腺肿瘤整形与乳房重建专家共识(2022年版)》(简称2022年版共识)在2020年版共识的基础上增加了乳腺腔镜手术章节。2022年版共识介绍了乳腺腔镜手术的安全性、适应证、操作技术及可能的并发症,并进行了文献汇总。基于已发表的研究结果,乳腺癌腔镜NSM联合假体乳房重建术复发率低、腺体残留率低、并发症发生率低、适应证范围广、手术操作简单易学,值得广泛推广。但目前已发表研究多为单中心、回顾性研究,期待正在开展的前瞻性临床试验结果的公布,证实乳腺癌腔镜NSM联合假体乳房重建手术的效能,进一步推动该术式的规范应用。

关键词: 乳腺肿瘤, 腔镜, 乳房重建, 微创手术

Abstract: In recent years, endoscopic breast surgery, represented by endoscopic nipple-areola-sparing mastectomy (NSM) plus prosthetic breast reconstruction, has been widely carried out in China, but there is still a lack of uniform technical specifications. Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition) (referred to as the 2022 edition consensus) adds a chapter on breast endoscopic surgery based on the 2020 edition consensus. The 2022 edition consensus introduces the safety, indications, operation techniques, and possible complications of breast endoscopic surgery, and summarizes the literature. Based on published research results, breast reconstruction surgery with endoscopic NSM combined with prosthesis has a low recurrence rate, low glandular residual rate, low complication rate, a wide range of indications, and simple operation, and is easy to learn and worthy of widespread promotion. However, most of the published studies are single-center and retrospective studies, and it is expected that the results of prospective clinical trials under way will be published to confirm the efficacy of endoscopic NSM combined with prosthesis breast reconstruction surgery, and further promote the standard application of this surgery.

Key words: breast cancer, endoscopy, breast reconstruction, minimally invasive surgery